로딩 중…
지수 로딩 중…
인바디
041830· KOSDAQ· Health Care· Health Care Equipment & Services
₩46,800+0.54%
2026-11-02
Financials
Valuation Metrics
인바디's Market Cap is ₩6309B. At end of 2025 it was ₩4415B. Ranked #372 of 2,410 in KR market (top 15%), #122 of 1,631 on KOSDAQ (top 7%), #9 of 94 in Health Care Equipment & Services (top 10%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 630.91B KRW | KR#372/2,410 Sec#9/94 |
| Revenue | 263.89B KRW | KR#888/2,410 Sec#9/94 |
| Net Income | 46.57B KRW | KR#440/2,410 Sec#8/94 |
| Total Assets | 381.13B KRW | KR#900/2,410 Sec#16/94 |
| Net Assets | 330.55B KRW | KR#685/2,410 Sec#12/94 |
| Employees | 415 | KR#585/2,410 Sec#14/94 |
| Value | ||
| P/E | 13.55x | KR#1,049/2,410 Sec#31/94 |
| P/B | 1.91x | KR#1,966/2,410 Sec#69/94 |
| PEG | 0.25x | KR#624/2,410 Sec#25/94 |
| P/S | 2.39x | KR#1,938/2,410 Sec#59/94 |
| EV/EBITDA | 11.36x | KR#732/2,410 Sec#25/94 |
| FCF Yield | 4.58% | KR#911/2,410 Sec#26/94 |
| Profitability | ||
| ROE | 14.09% | KR#369/2,410 Sec#13/94 |
| ROA | 12.22% | KR#182/2,410 Sec#10/94 |
| Op. Margin | 18.99% | KR#181/2,410 Sec#14/94 |
| Revenue Growth | 21.30% | KR#516/2,410 Sec#28/94 |
| Earnings Growth | 53.78% | KR#540/2,410 Sec#25/94 |
| Financial Health | ||
| Debt Ratio | 15.30% | KR#254/2,410 Sec#15/94 |
| Total Debt | 291.5M KRW | KR#2,006/2,410 Sec#80/94 |
| FCF | 28.86B KRW | KR#424/2,410 Sec#6/94 |
| Cash | 61.80B KRW | KR#664/2,410 Sec#14/94 |
| Current Ratio | 6.67x | KR#182/2,410 Sec#16/94 |
| Net Debt/EBITDA | -1.23x | KR#332/2,410 Sec#11/94 |
| Dividend | ||
| Div. Yield | 1.29% | KR#1,080/2,410 Sec#35/94 |
| Div. Growth | 50.00% | KR#228/2,410 Sec#13/94 |
| Performance | ||
| 1Y Return | 63.35% | KR#117/2,410 Sec#3/94 |
| 1M Return | -10.17% | KR#1,315/2,410 Sec#48/94 |
| From 52W High | -36.33% | KR#595/2,410 Sec#18/94 |
| 1Y MDD | -35.52% | KR#404/2,410 Sec#9/94 |
| Trading | ||
| Volume | 50,572 shares | KR#1,228/2,410 Sec#50/94 |
| Trading Value | 2.32B KRW | KR#472/2,410 Sec#11/94 |
| Foreign Own. | 33.00% | KR#95/2,410 Sec#2/94 |
| Per Share | ||
| EPS | 3,455 KRW | KR#304/2,410 Sec#5/94 |
| BPS | 24,520 KRW | KR#454/2,410 Sec#5/94 |
Company Info
동사는 1996년 전자의료기기 제조·판매 목적으로 설립되어 2000년 코스닥 상장, 2014년 인바디로 상호 변경함. 서울 본사와 국내외 총 17개 법인으로 구성된 글로벌 의료기기 제조회사로, 체성분분석기, 자동혈압계, 신장계 등을 생산하며 주요 국가에 법인을 운영 중임. 체성분분석기 기반 헬스케어 전자의료기기 사업과 AI 접목으로 새로운 사업모델을 준비하며 소프트웨어 관련 신성장을 추구하고 있음. 인바디는 1996년에 설립되었으며 서울시 강남구에 본사를 두고 있습니다.